Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Clinical Trial ID NCT03309722

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03309722

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance. Cancer Res 2013 1.29
2 The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut 2015 1.03
3 A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget 2016 0.92
4 Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget 2015 0.86
5 miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer. Mol Cancer Res 2015 0.79
6 Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblasts. J Vis Exp 2014 0.75
Next 100